ELAN (Elanco Animal Health) ROCE %: 4.94% (As of Mar. 2026)

What is Elanco Animal Health ROCE %?

Elanco Animal Health ELAN +3.36% 66 ROCE % is 4.94% as of Mar. 2026. GuruFocus rates ELAN with a GF Score™ of 66/100 and a GF Value™ of $15.57 (Significantly Overvalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elanco Animal Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.94%.

Elanco Animal Health (NYSE:ELAN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elanco Animal Health ROCE % Related Terms

Elanco Animal Health ROCE % Historical Data

* Premium members only.

The historical data trend for Elanco Animal Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanco Animal Health ROCE % Chart

Elanco Animal Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-2.20

1.18

-6.82

5.92

-0.03

Elanco Animal Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															3.48	2.43	0.07	-6.00	4.94

66GF Score

Elanco Animal Health Inc ELAN

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Elanco Animal Health ROCE % Calculation

Elanco Animal Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-4	/	( ( (12614 - 1315)	+	(13358 - 1597) )	/ 2 )
	=	-4	/	( (11299	+	11761)	/ 2 )
	=	-4	/	11530
	=	-0.03 %

Elanco Animal Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	576	/	( ( (13358 - 1597)	+	(13222 - 1662) )	/ 2 )
	=	576	/	( ( 11761	+	11560 )	/ 2 )
	=	576	/	11660.5
	=	4.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 4.94% mean?

Elanco Animal Health (ELAN) has a ROCE % of 4.94% as of Mar. 2026.

Is Elanco Animal Health's ROCE % too high?

Elanco Animal Health's current ROCE % is 4.94%. The Drug Manufacturers industry median ROCE % is 7.00. Elanco Animal Health's value of 4.94% is 29.4% below this industry median. Overall, Elanco Animal Health has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Elanco Animal Health's ROCE % compare to RGC and NBIX?

Elanco Animal Health's ROCE % of 4.94% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Elanco Animal Health's value of 4.94% is 29.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elanco Animal Health's current ROCE % of 4.94% is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elanco Animal Health's current ROCE % is 4.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Elanco Animal Health stock overvalued right now?

Based on GuruFocus' analysis, Elanco Animal Health (ELAN) is currently considered Significantly Overvalued. The stock's GF Value™ is $15.57, compared to a current price of $23.96 — trading 53.9% above its estimated fair value. The current ROCE % is 4.94% and 29.4% below the Drug Manufacturers industry median of 7.00. Elanco Animal Health's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Elanco Animal Health (ELAN), the current ROCE % is 4.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elanco Animal Health (ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of $23.96 is trading 53.9% above its estimated GF Value™ of $15.57. GuruFocus considers Elanco Animal Health to be Significantly Overvalued.

Key valuation signals for ELAN:

ROCE %: 4.94%
GF Value™: $15.57 vs. price of $23.96 (53.9% above fair value)
GF Score™: 66/100 with 4 warning signs
Industry Position: 29.4% below the Drug Manufacturers median

No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies RGC NBIX ALKS LNTH HIMS LQDA VTRS INDV AMRX KNSA XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges 5EA:Germany

Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221

Website https://www.elanco.com

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

66GF Score

Get the complete analysis for ELAN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.96

Price

$15.57

GF Value

View ELAN Analysis

See ROCE % data for all stocks →